Published in Eur J Cardiothorac Surg on January 19, 2005
Aspirin resistance in off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg (2012) 1.49
Aspirin resistance. Adv Hematol (2009) 0.83
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery. Eur Heart J (2014) 0.82
Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations. Int J Angiol (2011) 0.80
The influence of heparin resistance on postoperative complications in patients undergoing coronary surgery. Med Sci Monit (2012) 0.75
Preoperative aspirin resistance does not increase myocardial injury during off-pump coronary artery bypass surgery. J Korean Med Sci (2011) 0.75
Who failed to enroll in Medicare Part D, and why? Early results. Health Aff (Millwood) (2006) 3.44
Is size-reducing ascending aortoplasty with external reinforcement an option in modern aortic surgery? Eur J Cardiothorac Surg (2007) 2.30
Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Heart Rhythm (2012) 1.91
Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis. J Thorac Cardiovasc Surg (2009) 1.51
A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation. Thromb Haemost (2012) 1.41
Beta-blocker prophylaxis for atrial fibrillation after coronary artery bypass grafting in patients with sympathovagal imbalance. Ann Thorac Surg (2007) 1.41
Plan selection in Medicare Part D: evidence from administrative data. J Health Econ (2013) 1.25
Stock Market Expectations of Dutch Households. J Appl Econ (Chichester Engl) (2011) 1.22
Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects. Thromb Haemost (2015) 1.14
Recurrent embolism in the course of marantic endocarditis. Ann Thorac Surg (2005) 1.13
Towards a definition of aspirin resistance: a typological approach. Platelets (2002) 1.00
Stroke as a first manifestation of ovarian cancer. J Neurooncol (2005) 1.00
Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease. J Am Coll Cardiol (2013) 1.00
Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Eur J Cardiothorac Surg (2008) 0.99
Left ventricular assist device in a patient with a concomitant subcutaneous implantable cardioverter defibrillator. Circ Arrhythm Electrophysiol (2013) 0.93
Pharmacophore definition and three-dimensional quantitative structure-activity relationship study on structurally diverse prostacyclin receptor agonists. Mol Pharmacol (2002) 0.92
Primary and secondary prevention of ventricular arrhythmias in dilated cardiomyopathy: nonsustained, sustained, and incessant. Int Heart J (2009) 0.91
Determination of aspirin responsiveness by use of whole blood platelet aggregometry. Clin Chem (2007) 0.90
Insulation failure and externalized conductor of a single-coil Kentrox lead: an ongoing story? J Cardiovasc Electrophysiol (2014) 0.90
Ca2+ sensitizer superior to catecholamine during myocardial stunning? Eur J Cardiothorac Surg (2008) 0.88
Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br J Clin Pharmacol (2003) 0.88
Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart. Cardiovasc Res (2008) 0.87
Gene expression in acute Stanford type A dissection: a comparative microarray study. J Transl Med (2006) 0.87
Dipyrone (metamizole) markedly interferes with platelet inhibition by aspirin in patients with acute and chronic pain: A case-control study. Eur J Anaesthesiol (2016) 0.87
Clinical implications of aspirin resistance. Thromb Haemost (2008) 0.87
Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury. Circulation (2005) 0.85
Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study. Eur Arch Psychiatry Clin Neurosci (2011) 0.84
Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets. Platelets (2009) 0.84
Genetic variation of TLR4 influences immunoendocrine stress response: an observational study in cardiac surgical patients. Crit Care (2011) 0.84
Abdominal complications following open-heart surgery: a report of 12 cases and review of the literature. Acta Cardiol (2006) 0.84
Alternative splicing of platelet cyclooxygenase-2 mRNA in patients after coronary artery bypass grafting. Thromb Haemost (2007) 0.84
Long-term follow-up of sudden cardiac arrest survivors and electrophysiologically guided antiarrhythmic therapy. Cardiology (2003) 0.83
Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man. Behav Brain Res (2003) 0.83
Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. Eur Heart J (2006) 0.83
In vivo echocardiographic imaging of transplanted human adult stem cells in the myocardium labeled with clinically applicable CliniMACS nanoparticles. J Am Soc Echocardiogr (2006) 0.83
Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets. Eur J Pharmacol (2013) 0.83
Evidence for palliative enlargement of the right ventricular outflow tract in severe tetralogy of Fallot. Eur J Cardiothorac Surg (2005) 0.83
The use of autologous platelet gel (APG) for high-risk patients in cardiac surgery -- is it beneficial? Perfusion (2009) 0.82
Cyclooxygenase COX-2a, a novel COX-2 mRNA variant, in platelets from patients after coronary artery bypass grafting. Thromb Haemost (2004) 0.81
Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials. Eur J Cardiothorac Surg (2006) 0.81
Independency of myocardial stunning of endothelial stunning? Basic Res Cardiol (2007) 0.81
Flow cytometry analysis of platelet cyclooxygenase-2 expression: induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass grafting. Br J Haematol (2002) 0.81
Suit the action to the word, the word to the action: Hypothetical choices and real decisions in Medicare Part D. J Health Econ (2012) 0.81
Effects of direct mechanical ventricular assistance on regional myocardial function in an animal model of acute heart failure. Artif Organs (2003) 0.80
Activation of IP and EP(3) receptors alters cAMP-dependent cell migration. Eur J Pharmacol (2002) 0.80
Phrenic nerve stimulation in CRT patients and benefits of electronic lead repositioning: the ERACE trial. J Interv Card Electrophysiol (2013) 0.79
Detection and duration of aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg (2008) 0.79
Surgery for severe aortic stenosis with low transvalvular gradient and poor left ventricular function -- a single centre experience and review of the literature. J Cardiothorac Surg (2007) 0.79
Why does height matter for educational attainment? Evidence from German children. Econ Hum Biol (2011) 0.79
Rupture of a saphenous vein coronary artery bypass graft due to Aspergillus necrotizing vasculitis. Ann Thorac Surg (2005) 0.79
Oxygenation failure after cardiac surgery: early re-intubation versus treatment by nasal continuous positive airway pressure (NCPAP) or non-invasive positive pressure ventilation (NPPV). Monaldi Arch Chest Dis (2008) 0.79
A novel activation process of protein kinase C in the remote, non-ischemic area of an infarcted heart is mediated by angiotensin-AT1 receptors. J Mol Cell Cardiol (2003) 0.78
Are anchoring vignettes ratings sensitive to vignette age and sex? Health Econ (2011) 0.78
β-Adrenergic signaling and response to pressure overload in transgenic mice with cardiac-specific overexpression of inducible NO synthase. Nitric Oxide (2011) 0.78
Aortic valve replacement in octogenarians: outcome and predictors of complications. Hellenic J Cardiol (2011) 0.78
Risk factors of ventricular tachyarrhythmias after coronary artery bypass grafting. Int J Cardiol (2005) 0.78
[The isolated rabbit heart: comparison between five different modifications]. Herz (2002) 0.77
Trapidil protects ischemic hearts from reperfusion injury by stimulating PKAII activity. Cardiovasc Res (2003) 0.77
Soluble CD40L release as test for functional platelet loss. Clin Lab (2012) 0.77
Delayed preconditioning via Angiotensin-converting enzyme inhibition: pros and cons from an experimental study. Clin Exp Pharmacol Physiol (2006) 0.77
Human cyclooxygenase-1b is not the elusive target of acetaminophen. Eur J Pharmacol (2006) 0.76
Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes. Vascul Pharmacol (2011) 0.76
Aspirin "resistance". Blood Cells Mol Dis (2006) 0.76
Metabolic monitoring of postischemic myocardium during intermittent warm-blood cardioplegic administration. Tex Heart Inst J (2010) 0.76
Prediction of atrial fibrillation after coronary artery bypass grafting: the role of chemoreflex-sensitivity and P wave signal averaged ECG. Int J Cardiol (2006) 0.76
Effects of selective cyclooxygenase isoform inhibition on systemic prostacyclin synthesis and on platelet function at rest and after exercise in healthy volunteers. Platelets (2007) 0.76
Where does it lead? Imaging features of cardiovascular implantable electronic devices on chest radiograph and CT. Korean J Radiol (2011) 0.75
Functional testing methods for the antiplatelet effects of aspirin. Biomark Med (2011) 0.75
Comment on point: counterpoint "in health and in a normoxic environment, VO2 max is/is not limited primarily by cardiac output and locomotor muscle blood flow". Vol 100: 744-8, 2006. CO and perfusion of the exercising muscle are different entities. J Appl Physiol (1985) (2006) 0.75
A modification to the Manouguian aortoplasty for biological valve implantation in patients with small (< or =19 mm) aortic anuli--rationale and benefit. Tex Heart Inst J (2008) 0.75
Clopidogrel "resistance" and statin cotreatment - significant for cardiocoronary prevention in real life? Thromb Haemost (2005) 0.75
Clopidogrel "resistance". Thromb Haemost (2004) 0.75
Platelet inhibition by aspirin after aortic valve replacement. J Thorac Cardiovasc Surg (2006) 0.75
Anticoagulation during extracorporeal circulation under conditions of an ongoing systemic inflammatory response syndrome: effects of heparin. Perfusion (2005) 0.75
Differential effects of factor IIa inhibitors on the endogenous thrombin potential. Ther Drug Monit (2008) 0.75
Intraoperative comparison of a subthreshold test pulse with the standard high-energy shock approach for the measurement of defibrillation lead impedance. J Cardiovasc Electrophysiol (2006) 0.75
Preconditioning: myocardial function and energetics during coronary hypoperfusion and reperfusion. Ann Thorac Surg (2002) 0.75
Coronary flow reserve in hypertrophic obstructive cardiomyopathy assessed by intracoronary Doppler catheter. Kardiol Pol (2004) 0.75
Ventricular containment in the prophylaxis of experimental dilated cardiomyopathy. Interact Cardiovasc Thorac Surg (2003) 0.75
Mechanical heart support using intraaortic balloon counterpulsation. A retrospective view and current perspectives. Acta Cardiol (2004) 0.75
Norepinephrine-induced delayed cardioprotection against stunning is at the expense of a higher postischemic arrhythmia rate. Cardiovasc Surg (2003) 0.75
Thromboxane Formation Assay to Identify High On-Treatment Platelet Reactivity to Aspirin. Pharmacology (2017) 0.75
[Protective effects of a delta-opioid-receptor agonist and an oxygen radical scavenger on postischemic hearts]. Herz (2004) 0.75
Rotation of the exo-methylene group of (R)-3-methylitaconate catalyzed by coenzyme B(12)-dependent 2-methyleneglutarate mutase from Eubacterium barkeri. J Am Chem Soc (2002) 0.75
Anesthetic management of neonates with congenital complete atrioventricular heart block undergoing pacemaker implantation. J Cardiothorac Vasc Anesth (2005) 0.75
Aspirin-induced platelet inhibition in patients undergoing cardiac surgery. Platelets (2007) 0.75
Per-period co-payments and the demand for health care: evidence from survey and claims data. Health Econ (2013) 0.75
Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE). Thromb Haemost (2017) 0.75
Minimally invasive catheter procedures to assist complicated pacemaker lead extraction and implantation in the operating room. Cardiovasc Intervent Radiol (2010) 0.75
Determination of thromboxane formation, soluble CD40L release and thrombopoietin clearance in apheresis platelet concentrates. Platelets (2011) 0.75